Eli Lilly’s Obesity Drug Performs Well in Two Late-Stage Studies

July 29, 2023

First T-cell treatment for a solid tumor Amtagvi approved by the FDA from Iovance

February 23, 2024

Caribou Gets CAR-T Boost Ahead of Phase 3 Trial

June 16, 2026

Must Read

Top 10 AI Applications Transforming Pharmaceutical Market Access

June 23, 2026

The Future of Scientific Engagement in an AI-Driven World

June 23, 2026

cAMPfield Plans Mid-Stage Ulcerative Colitis and Crohn’s Disease Trials for Prifemilast

June 23, 2026

About Us

Life Sciences Voice is the leading resource for life sciences executives to get crucial insights, explore the latest innovations, and learn about industry trends. Life Sciences Voice provides the community with thought-provoking commentary in multiple formats covering a range of issues from drug discovery to commercial success.

Early research shows that Lilly’s Verve strategy is successful in lowering cholesterol

Kailera Details Nasdaq IPO Plans to Raise Up to $528.5 Million for Obesity Drug Development

Avalyn Files for IPO to Fund Late-Stage Development of Inhaled Lung Disease Therapies

Merck Pays $20 Million Upfront to Access Quotient’s Somatic Genomics Platform for IBD Research

cAMPfield Plans Mid-Stage Ulcerative Colitis and Crohn’s Disease Trials for Prifemilast

Definium’s LSD Formula Delivers Stunning Late-Stage Results

Merck Reports Positive Phase 3 Result for Tulisokibart in Ulcerative Colitis

Phase 3 Lagoon Trial Misses Survival Goal for Jazz’s Zepzelca in Second-Line Small Cell Lung Cancer

Eli Lilly Secures Global Rights to AlzeCure Alzheimer’s Drug Candidate in Deal Worth Over $1 Billion

Ascidian & Lilly Pen RNA Exon Editing Agreement for Genetic Kidney Issues

Travere Licenses Civorebrutinib From Everest Medicines in Deal Worth Up to $1.14 Billion

Alnylam Inks $2B Agreement With Inceptive to Change sIRNA Design With AI Leader

Chugai and Gero Partner to Develop Antibodies for Age-Related Diseases Using AI

J&J MedTech presents the first Ottava surgical robot clinical cases

Wisp Launches Weight Care Vertical for Women with Hormonal Imbalances

Top 10 AI Applications Transforming Pharmaceutical Market Access

The Future of Scientific Engagement in an AI-Driven World

Top 10 Data Architecture Challenges in Modern Pharma Organizations

The Next Evolution of Decentralized Clinical Trials

Tag: Novo Advances Amycretin

Novo Advances Amycretin Into Phase 3 Development for Type 2 Diabetes

Editor Picks

Eli Lilly’s Obesity Drug Performs Well in Two Late-Stage Studies

First T-cell treatment for a solid tumor Amtagvi approved by the FDA from Iovance

Caribou Gets CAR-T Boost Ahead of Phase 3 Trial

Must Read

Top 10 AI Applications Transforming Pharmaceutical Market Access

The Future of Scientific Engagement in an AI-Driven World

cAMPfield Plans Mid-Stage Ulcerative Colitis and Crohn’s Disease Trials for Prifemilast

Hot Topics

About Us

Follow Us